|
Volumn 24, Issue 1 SUPPL. 2, 1997, Pages
|
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUOROURACIL;
GRANULOCYTE COLONY STIMULATING FACTOR;
HYDROXYUREA;
PACLITAXEL;
ADULT;
AGED;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTINUOUS INFUSION;
DERMATITIS;
DRUG FEVER;
FEMALE;
HEAD AND NECK CANCER;
HUMAN;
HUMAN TISSUE;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MUCOSA INFLAMMATION;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
RECURRENT CANCER;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTOPENIA;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
FEASIBILITY STUDIES;
FEMALE;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
HYDROXYUREA;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PACLITAXEL;
REMISSION INDUCTION;
|
EID: 0031055488
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (10)
|
References (14)
|